CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 177 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $187 | +81.6% | 6,298 | +10.4% | 0.00% | +100.0% |
| Q2 2023 | $103 | +12.0% | 5,706 | -0.1% | 0.00% | 0.0% |
| Q1 2023 | $92 | -28.1% | 5,709 | -18.1% | 0.00% | 0.0% |
| Q4 2022 | $128 | -99.9% | 6,968 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $137,000 | +6.2% | 6,968 | +1.1% | 0.00% | 0.0% |
| Q2 2022 | $129,000 | -18.9% | 6,894 | -4.6% | 0.00% | 0.0% |
| Q1 2022 | $159,000 | -64.0% | 7,228 | -53.6% | 0.00% | -50.0% |
| Q4 2021 | $442,000 | – | 15,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
| Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
| Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
| Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
| 5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
| First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
| BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
| BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
| Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |